46 related articles for article (PubMed ID: 20512542)
1. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy.
Lafata KJ; Hong JC; Geng R; Ackerson BG; Liu JG; Zhou Z; Torok J; Kelsey CR; Yin FF
Phys Med Biol; 2019 Jan; 64(2):025007. PubMed ID: 30524018
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of Imaging Patterns of Lung Cancer following Radiation Therapy.
Strange TA; Erasmus LT; Ahuja J; Agrawal R; Shroff GS; Truong MT; Strange CD
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892105
[TBL] [Abstract][Full Text] [Related]
3. Local Recurrence Risk Score to Predict Relapse after Stereotactic Body Radiation Therapy for Lung Tumors.
Pougnet I; Habert P; Delcourt S; Boucekine M; Wong S; Zacchariotto A; Muracciole X; Gaubert JY; Padovani L
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362674
[TBL] [Abstract][Full Text] [Related]
4. CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT).
Al-Umairi R; Tarique U; Moineddin R; Jimenez-Juan L; Kha LC; Cheung P; Oikonomou A
Cancer Imaging; 2022 Sep; 22(1):51. PubMed ID: 36114585
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning with Multimodal Integration for Predicting Recurrence in Patients with Non-Small Cell Lung Cancer.
Kim G; Moon S; Choi JH
Sensors (Basel); 2022 Aug; 22(17):. PubMed ID: 36081053
[TBL] [Abstract][Full Text] [Related]
6. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Yang H; Wang L; Shao G; Dong B; Wang F; Wei Y; Li P; Chen H; Chen W; Zheng Y; He Y; Zhao Y; Du X; Sun X; Wang Z; Wang Y; Zhou X; Lai X; Feng W; Shen L; Qiu G; Ji Y; Chen J; Jiang Y; Liu J; Zeng J; Wang C; Zhao Q; Yang X; Hu X; Ma H; Chen Q; Chen M; Jiang H; Xu Y
Front Oncol; 2022; 12():967360. PubMed ID: 35982975
[TBL] [Abstract][Full Text] [Related]
7. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
8. Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis.
Hayashi S; Tanaka H; Hoshi H
Thorac Cancer; 2015 Mar; 6(2):186-93. PubMed ID: 26273357
[TBL] [Abstract][Full Text] [Related]
9. Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy.
Halpenny D; Ridge CA; Hayes S; Zheng J; Moskowitz CS; Rimner A; Ginsberg MS
Clin Imaging; 2015; 39(2):254-8. PubMed ID: 25571791
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer.
Hayashi S; Tanaka H; Kajiura Y; Ohno Y; Hoshi H
Radiat Oncol; 2014 Jun; 9():138. PubMed ID: 24935216
[TBL] [Abstract][Full Text] [Related]
11. New techniques for assessing response after hypofractionated radiotherapy for lung cancer.
Mattonen SA; Huang K; Ward AD; Senan S; Palma DA
J Thorac Dis; 2014 Apr; 6(4):375-86. PubMed ID: 24688782
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography appearances of local recurrence after stereotactic body radiation therapy for stage I non-small-cell lung carcinoma.
Kato S; Nambu A; Onishi H; Saito A; Kuriyama K; Komiyama T; Marino K; Araki T
Jpn J Radiol; 2010 May; 28(4):259-65. PubMed ID: 20512542
[TBL] [Abstract][Full Text] [Related]
13. Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
Peulen H; Mantel F; Guckenberger M; Belderbos J; Werner-Wasik M; Hope A; Giuliani M; Grills I; Sonke JJ
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):134-41. PubMed ID: 27325481
[TBL] [Abstract][Full Text] [Related]
14. Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis.
Kim TH; Woo S; Halpenny DF; Kim YJ; Yoon SH; Suh CH
Eur J Radiol; 2020 Jun; 127():108978. PubMed ID: 32298960
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Primer for Radiologists.
Febbo JA; Gaddikeri RS; Shah PN
Radiographics; 2018; 38(5):1312-1336. PubMed ID: 30074857
[TBL] [Abstract][Full Text] [Related]
17. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.
Wink KCJ; van Baardwijk A; Troost EGC; De Ruysscher D
Cancer Treat Rev; 2017 May; 56():8-15. PubMed ID: 28437679
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
